Current status: 878 hESC lines, 3708 hiPSC lines, and 112 clinical studies, and 640 certificates
Monthly statistic from Apr 1, 2023
Posted on April 1, 2023
| total lines | 4586 |
| hESC lines | 878 |
| hiPSC lines | 3708 |
| derivation countries | 45 |
| projects | 264 |
| providers | 801 |
| clinical studies | 112 |
| subclones | 2065 |
| certificates | 640 |
| cell line certificates | 505 |
| project certificates | 135 |